Brain Stimulation + VR
for Stress and Sleep Management

"One of four technologies
innovating mental health."

- Forbes

Kortex® clones the brain stimulation technology of the Fisher Wallace Stimulator® and is strictly intended to manage stress and sleep, without a prescription.

Kortex® works by stimulating serotonin production, lowering cortisol and modulating brain activity, as proven in published studies. Combined with meditative, cathartic VR content, Kortex® provides superior stress and sleep management results.

Scientific Validation

Fisher Wallace brain stimulation technology has been validated in multiple published studies, including biomarker studies and randomized controlled trials.


Featured VR Title

Product Reviews

Listen to Corporal (US Marine Corps, Ret.) Logan Shield and General (US Army, Ret.) Stephen Xenakis as they discuss the technology.

Our Medical Advisory Board

In The News

As featured in:

Read More

How It Works


Meir Kryger, M.D., FRCPC

Meir Kryger, MD, FRCPC, joined the Yale School of Medicine and the VA Connecticut Health System, November 2011. Previously he was Professor of Medicine, University of Manitoba where he established the first clinical laboratory studying patients with sleep breathing problems in Canada. Dr. Kryger has published more than 200 research articles and book chapters. He is the chief editor of the most widely used textbook in sleep medicine, The Principles and Practice of Sleep Medicine, currently in its 5th edition and is the author of A Woman's Guide to Sleep Disorders, the Atlas of Clinical Sleep Medicine, and Kryger’s Sleep Medicine Review. Dr. Kryger was the first to diagnose and report obstructive sleep apnea in North America. His research was the first to show the feasibility of using noninvasive techniques to ventilate post-polio patients in their homes. His laboratory elucidated the interaction between heart failure and sleep respiration publishing the first systematic study of oxygen in this condition. He has been president of both the Canadian Sleep Society and the American Academy of Sleep Medicine. He is on the Board of Directors of the National Sleep Foundation in Washington, D.C., and served as Board. He received the William C. Dement Award for Academic Achievement in sleep medicine. In 2011 he received a Distinguished Scientist Award from the Canadian Sleep Society at the meeting of the World Association of Sleep Medicine.




Mitchell Rosenthal, M.D.

Mitchell S. “Mitch” Rosenthal, M.D. is president of the Rosenthal Center for Addiction Studies. A pioneer in the treatment of substance abuse, Dr. Rosenthal was founder of Phoenix House, the nation's leading private, non-profit provider of substance abuse services. He began work in the field in 1965 as a psychiatrist at the U.S. Naval Hospital in Oakland, California (1965-1967), where he established the first service-sponsored therapeutic community, successfully treating both alcoholics and drug addicts. As a leading advocate for the treatment community, Dr. Rosenthal chaired the New York State Advisory Council on Substance Abuse from 1985 to 1997. He has been a White House advisor on drug abuse and a special consultant to the Office of National Drug Control Policy. He is a lecturer in psychiatry at Columbia University College of Physicians and Surgeons, and was awarded an honorary degree (Doctor of Humane Letters) by SUNY Downstate Medical Center in 2002.


Stephen N. Xenakis, M.D.

Dr. Xenakis served 28 years in the United States Army as a medical corps officer. He held a wide variety of assignments as a clinical psychiatrist, staff officer, and senior commander including Commanding General of the Southeast Army Regional Medical Command. Dr. Xenakis has written widely on medical ethics, military medicine, and the treatment of detainees. He has published editorials in the Washington Post and a number of other national magazines and journals, including book chapters and legal reviews. Dr. Xenakis has an active clinical and consulting practice, and is currently working on the clinical applications of quantitative electroencephalography (QEEG) to brain injury and other neurobehavioral conditions.



Lauri Liskin, M.D.

Dr. Liskin is Clinical  Assistant  Professor of  Psychiatry at Weill Cornell Medical College and on the attending staff at New York Presbyterian Hospital. Dr. Liskin entered medicine with a foundation in neuroscience and neurobehavioral research.  She was the recipient of a Howard Hughes Medical Institute Award and published  electrophysiology research on Circadian Rhythms.  She did her Psychiatry residency training at Cornell, a Forensic Psychiatry fellowship at Albert Einstein College of Medicine, and completed the Psychodynamic Psychotherapy program at the Columbia Center for Psychoanalytic Training & Research. She has been in private practice in New York City since 1999. Dr. Liskin has broad clinical experience with diverse patient populations in a wide array of inpatient and outpatient settings in various public and private institutions. Her expertise in integrative psychiatry evolved from her focus  on patients’ treatment needs and her commitment to ongoing education as a psychopharmacologist and psychotherapist. As a clinician assessing psychiatric adverse events, Dr. Liskin has been involved in obesity studies at the Comprehensive Weight Control Program affiliated with Weill-Cornell.  Dr. Liskin is the recipient of a Creativity and Leadership Commendation from the Association of Women Psychiatrists. She currently serves on the American Psychiatric Association’s  New York State District Branch Practice Committee as well as its Integrative Psychiatry Task Force.



J Roberto Trujillo, M.D., Sc.D.

Dr. Trujillo is the Chairman and CEO of TruCytonics Institute & NeuroCytonix, Inc., at the Montgomery Biotechnology campus of Johns Hopkins University. His current focus is on translation research of neural tissue engineering (quantum magnetic resonance) for the treatment of neurodegenerative diseases, including Alzheimer’s disease, stroke and Parkinson’s disease. He graduated medical school with Suma Cum Laude Honors from University Autonomous of Mexico State. Following an internship in Medicine at Baylor College of Medicine, he completed a two-year clinical neurological and neurosurgical fellowship at Texas Medical Center. After receiving a Training Award from NIH, Dr. Trujillo obtained his Doctor of Science degree in Neurosciences and Molecular Virology at Harvard University. As a pioneer in the field of neurovirology at Harvard, Dr. Trujillo founded the Pan-American Society of NeuroVirology in 2000. He has held several faculty positions, including at Harvard University, the National Institute of Neurological Disorders and Stroke, NIH and the University of Maryland. Since 2010, he founded several successful biotech companies with great influence in Latin American markets and in the biotechnological corridor of the State of Maryland. Dr. Trujillo has published over 50 scientific manuscripts and reviews in neurosciences, immunology, cancer and molecular virology including NeuroAIDS. He is the co-inventor of CERCA, a U.S. patented photodynamic therapeutic medical device for the prevention of cervical cancer. Dr. Trujillo is a leader of medical sciences of the Americas, and he has received numerous awards, professional titles, and honorary doctor degrees. He has been recognized as the “100 Most Influential Professional Mexican in the USA”. Dr. Trujillo sits on several consulting and scientific editorial boards.



Ronald Podell, M.D.

Dr. Podell is a board certified psychiatrist. He graduated with honors from Amherst College and received his medical degree from Columbia University. He completed his post-graduate psychiatry training at UCLA and was named to the Clinical Faculty in 1979. He served over 20 years as Assistant Clinical Professor of Psychiatry. He regularly teaches post-graduate courses for both mental health professionals and laymen and has been course director for two national symposia. Dr. Podell was one of the founding physicians for the Century City Hospital in Vitro Fertilization Program. He was then named to co-direct the hospital´s Center for Sexual Medicine, which offered multi-disciplinary treatment for sexual dysfunction. He co-founded the Center for Mood Disorders in West Los Angeles in 1984 and the Westridge Psychiatric Medical Group in 1989. Dr. Podell has published articles in academic and lay journals and is the author of Contagious Emotions – Staying well when your loved one is depressed. He has extensive media experience including local and national television, radio, newspapers and magazines. His most recent endeavor is the founding of the Center for Bio-Behavioral Science, a multi-disciplinary center devoted to the diagnosis of memory problems in older adults and attention and learning problems in young adults.




Robert Cancro, M.D.

Since 1976, Dr. Cancro has been a Professor and Chairman of the Department of Psychiatry at New York University School of Medicine, Director of Psychiatry at New York University Hospital and Director of the Nathan S. Kline Institute for Psychiatric Research. Dr. Cancro served as a Professor in the Department of Psychiatry at the University of Connecticut Health Center until 1976. Dr. Cancro is a widely published, internationally recognized psychiatrist and educator, having received numerous honors and awards. He is on the editorial board of several scientific journals and is an examiner for the American Board of Psychiatry and Neurology Inc. Dr. Cancro is a Fellow of the American Psychiatric Association, the American College of Psychiatrists and the American College of Physicians. He is also a member of the Expert Advisory Panel on Mental Health for the World Health Organization and the Research Advisory Committee of the United States Secret Service. Dr. Cancro is the President and a Director of the International Committee Against Mental Illness and Chairman of the Section on Psychiatric Rehabilitation of the World Psychiatric Association.


Sandlin Lowe, M.D.

Dr. Lowe is on the Faculty of the New York University School of Medicine and holds appointments in both the Department of Psychiatry and the Department of Physiology and Neuroscience. He is Consulting Psychiatrist to the Brain Research Laboratories and Collaborating Psychiatrist at the Center for Neuromagnetism. He also is the Chief of Psychiatry Assessment Services at Woodhull Medical Center.  Dr. Lowe is an expert in Translational Neuroscience and has created new paradigms for the conceptualization, evaluation and treatment of consciousness spectrum disorders in patients with brain injuries. The theoretical basis for this work is founded upon his research with Dr. Rodolfo Llinas and Dr. E. Roy John, two of the Fathers of modern day neuroscience. Lately, for personal reasons, his efforts have been directed towards autism spectrum disorders. Dr. Lowe has particular interest in combining small molecules and cellular and regenerative medicine techniques with applied field energy therapies in the design of new treatment protocols for autism.



Bruce Johnson, M.D.

Dr. Johnson is a Staff Psychiatrist at Crozer Medical Center.  Board-certified in psychiatry and neurology, and a certified psychoanalyst, Dr. Johnson’s specialties include psychoanalysis, psychotherapy, pharmacotherapy and depression.  Dr. Johnson earned his medical degree at George Washington Medical School, Washington, D.C.  He completed his internship at Ohio State University, in Columbus, Ohio and his residency at Saint Elizabeth’s Hospital in Washington, D.C. and Chestnut Lodge Hospital in Rockville, Maryland.  While serving in the military, Dr. Johnson served as Chief of Psychiatric Department at the Public Health Service Hospital in Baltimore, Maryland and as a consultant for the Peace Corps Volunteers.


Treatment Comparison

Return Policy & Insurance Reimbursement